<div id="readability-page-1"><p>Bayer Aktiengesellschaft reported earnings results for the third quarter and nine months ended September 30, 2025. For the third quarter, the company reported sales was EUR 9,660 million compared to EUR 9,968 million a year ago. Net loss was EUR 963 million compared to EUR 4,183 million a year ago. Basic loss per share from continuing operations was EUR 0.98 compared to EUR 4.26 a year ago. Diluted loss per share from continuing operations was EUR 0.98 compared to EUR 4.26 a year ago.<br/> For the nine months, sales was EUR 34,137 million compared to EUR 34,877 million a year ago. Net income was EUR 137 million compared to net loss of EUR 2,217 million a year ago. Basic earnings per share from continuing operations was EUR 0.14 compared to basic loss per share from continuing operations of EUR 2.26 a year ago. Diluted earnings per share from continuing operations was EUR 0.14 compared to diluted loss per share from continuing operations of EUR 2.26 a year ago.</p></div>

拜耳

拜耳(ADR)

<p>拜耳 Aktiengesellschaft 公布了 2025 年第三季度及前九个月的财报。第三季度销售额为 96.6 亿欧元，同比下降自 99.68 亿欧元，净亏损为 9.63 亿欧元，而去年为亏损 41.83 亿欧元。在前九个月，销售总额为 341.37 亿欧元，略低于去年的 348.77 亿欧元，但净收入改善至 1.37 亿欧元，而去年为亏损 22.17 亿欧元。持续经营业务的基本和稀释每股收益为 0.14 欧元，较去年亏损 2.26 欧元有所恢复</p>

拜耳股份公司公布了截至2025年9月30日的第三季度及九个月的财务业绩